rosai-dorfman disease with extranodal lesionsrosai-dorfman disease, is an idiopathic histiocytic...

1
Abstract Abstract Rosai-Dorfman Disease with Extranodal Lesions Kaori Hashimoto, MD 1)2) ; Shin Kariya, MD, PhD 3) ; Tetsuo Ooue, MD 2) ; Yasuhiko Yamashita, MD, PhD 2) ; Kikuko Naka, MD 2) ; Kazunori Nishizaki, MD, PhD 3) 1) Department of Otolaryngology-Head and Neck Surgery, Japanese Red Cross Okayama Hospital, Okayama, Japan 2) Department of Otolaryngology-Head and Neck Surgery, Fukuyama City Hospital, Hiroshima, Japan 3) Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan Rosai-Dorfman Disease with Extranodal Lesions Kaori Hashimoto, MD 1)2) ; Shin Kariya, MD, PhD 3) ; Tetsuo Ooue, MD 2) ; Yasuhiko Yamashita, MD, PhD 2) ; Kikuko Naka, MD 2) ; Kazunori Nishizaki, MD, PhD 3) 1) Department of Otolaryngology-Head and Neck Surgery, Japanese Red Cross Okayama Hospital, Okayama, Japan 2) Department of Otolaryngology-Head and Neck Surgery, Fukuyama City Hospital, Hiroshima, Japan 3) Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan Introduction Introduction Case Report Case Report References References Rosai-Dorfman disease is considered a benign disease, however the disease can be fatal because of combination of cellular infiltration and mass forming. Very careful management is required. Discussion Discussion Figure 2: Axial and Coronal T1-weighted MR images with gadolinium show the intracranial tumors. Conclusions Conclusions Objectives: Rosai-Dorfman disease is a rare condition of marrow hemopoietic stem-cell origin. Most patients present with lymphatic involvement, whereas less than one third of cases are extranodal presentations. Only about 5% of the extranodal cases involve bone. The purpose of this study is to present a case of Rosai-Dorfman disease with lymphadenopathy, intracranial tumors and bone lesions mimicking malignant neoplasm. Methods: Case report concerning the diagnosis and treatment of Rosai- Dorfman disease with extranodal presentation including intracranial tumors and multifocal bone lesions. Results: A 53 year-old man was admitted to our hospital because of three- month history of bilateral cervical lymphadenopathy. He also had a five-year history of dizziness. Computed tomography, magnetic resonance imaging and positron emission tomography showed cervical, mediastinal and inguinal lymphadenopathy. Intracranial tumors and pelvic bone lesions were also detected. The cervical lymph node biopsy confirmed the diagnosis of Rosai-Dorfman disease. The patient received oral prednisolone, and his neck pain was improved. The massive cervical lymph nodes and bone lesions didn’t progress. Conclusion: Rosai-Dorfman disease should be considered in the differential diagnosis of lymphadenopathy, even though the disease is rare. The predominant clinical manifestation of the disease is painless cervical lymphadenopathy. Rosai-Dorfman disease is considered a benign disease, however the disease can be fatal because of cellular infiltration and mass forming. The treatment for Rosai-Dorfman disease has not been established. Figure 1: Axial CT and positron emission tomography show multiple bilateral cervical lymphadenopathy (SUV MAX: 14.25). Rosai-Dorfman disease is a rare, benign, idiopatic, and non-neoplastic histiocytic disorder. It’s characterized by massive but painless cervical lymphadenopathy, fever, leukocytosis, increased erythrocyte sedimentation rate, and polyclonal hypergammaglobulinemia [1]. Most patients present with lympthatic involvement, whereas 43% of cases are extranodal presentations: eyelids, orbit, respiratory tract, salivary glands, skin, bone, testis, lung, kidney, central nervous system, thyroid and gastrointestinal tract [2]. Figure 3: Axial MR image shows multiple bone lesions of the skull. Figure 4: (A) Photomicrograph shows the foamy histiocytes, which contain intact lymphocytes and/or plasma cells within their cytoplasm, termed emperipolesis. (hematoxylin and eosin staining); (B) The histiocytes show positive reactions for S-100 protein in immunohistochemical staining. lymph node and intracranial tumor identified histiocytes that engulfed lymphocytes and plasma cells in their cytoplasm (emperipolesis) (Figure 4A). The immunohistochemical staining revealed positive S-100 staining of histiocytes (Figure 4B). Histopathological and immunohistochemical studies established the diagnosis of Rosai-Dorfman disease. The neck pain appeared, and the oral administration of prednisolone improved his symptoms. No evidence of residual or recurrent tumor in the intracranial lesion was identified. The size of bone lesions and lymph nodes were stable. Sinus histocytosis with massive lymphadenopathy, also known as Rosai-Dorfman disease, is an idiopathic histiocytic proliferation affecting lymph nodes. Histologically, the lesions consisted of variable numbers of pale-staining histiocytes with emperipolesis. In this case, the patient had multiple lymphadenopathy, central nervous system involvements and bone lesions. The differential diagnosis of Rosai-Dorfman disease is broad and includes malignant glioma, malignant lymphoma, histiocytosis X (Langerhans cell histiocytosis), sarcoidosis, metastatic tumors, granulomatous disease and meningioma [3][4]. Rosai-Dorfman disease has a long natural history with mostly benign course, and special treatment is not required. However, massive lymphadenopathy, extranodal involvement of multiple organs (kidney, lungs and liver), immunologic abnormalities and anemia can lead to a poor prognosis. The treatment modalities for Rosai- Dorfman disease include corticosteroids, chemotherapy with a combination of vinca alkaloids and alkylating agents, low-dose interferon, antibiotic therapy, radiation therapy and surgical treatment [5]. However, there is no established treatment for Rosai-Dorfman disease. A 53 year- old man was admitted to our hospital because of three- month history of bilateral massive painless cervical lymphadenopathy and five-year history of dizziness. On physical examination, he had enlarged bilateral cervical lymph nodes. He had normal vital signs and no neurological abnormality. Hematological and biochemical examinations were normal without leukocytosis and hypergammaglobulinemia. Computed tomography, magnetic resonance imaging and positron emission tomography showed cervical, mediastinal and inguinal lymphadenopathy. Intracranial tumors and multiple lytic bone lesions of the skull and pelvic bone were also detected (Figure 1-3). The patient underwent cervical lymph node biopsy and intracranial tumor resection. The histological examinations of the cervical 1) Rosai J, Dorfman RF. Arch Pathol. 1969 Jan;87(1):63-70. 2) Foucar E, Rosai J, Dorfman R. Semin Diagn Pathol. 1990 Feb;7(1):19-73. 3) Loh SY, Tan KB, Wong YS, et al. J Bone Joint Surg Am. 2004 Mar;86-A(3):595-8. 4) Fukushima T, Yachi K, Ogino A, et al. Neurol Med Chir (Tokyo). 2011;51(2):136-40. 5) Komp DM. Semin Diagn Pathol. 1990 Feb;7(1):83-6. A B Figure 5: Frontal (left) and lateral (right) view of CT-angiography show intracranial tumor with hypervascularity.

Upload: others

Post on 12-Feb-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

  • AbstractAbstract

    Rosai-Dorfman Disease with Extranodal LesionsKaori Hashimoto, MD 1)2); Shin Kariya, MD, PhD 3); Tetsuo Ooue, MD 2); Yasuhiko Yamashita, MD, PhD 2); Kikuko Naka, MD 2); Kazunori Nishizaki, MD, PhD 3)

    1) Department of Otolaryngology-Head and Neck Surgery, Japanese Red Cross Okayama Hospital, Okayama, Japan2) Department of Otolaryngology-Head and Neck Surgery, Fukuyama City Hospital, Hiroshima, Japan

    3) Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    Rosai-Dorfman Disease with Extranodal LesionsKaori Hashimoto, MD 1)2); Shin Kariya, MD, PhD 3); Tetsuo Ooue, MD 2); Yasuhiko Yamashita, MD, PhD 2); Kikuko Naka, MD 2); Kazunori Nishizaki, MD, PhD 3)

    1) Department of Otolaryngology-Head and Neck Surgery, Japanese Red Cross Okayama Hospital, Okayama, Japan2) Department of Otolaryngology-Head and Neck Surgery, Fukuyama City Hospital, Hiroshima, Japan

    3) Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

    IntroductionIntroduction

    Case ReportCase Report

    ReferencesReferences

    Rosai-Dorfman disease is considered a benign disease, however the

    disease can be fatal because of combination of cellular infiltration and mass

    forming. Very careful management is required.

    DiscussionDiscussion

    Figure 2: Axial and Coronal T1-weighted MR images with gadolinium show the intracranial tumors.

    ConclusionsConclusions

    Objectives: Rosai-Dorfman disease is a rare condition of marrow

    hemopoietic stem-cell origin. Most patients present with lymphatic

    involvement, whereas less than one third of cases are extranodal

    presentations. Only about 5% of the extranodal cases involve bone. The

    purpose of this study is to present a case of Rosai-Dorfman disease with

    lymphadenopathy, intracranial tumors and bone lesions mimicking malignant

    neoplasm.

    Methods: Case report concerning the diagnosis and treatment of Rosai-

    Dorfman disease with extranodal presentation including intracranial tumors

    and multifocal bone lesions.

    Results: A 53 year-old man was admitted to our hospital because of three-

    month history of bilateral cervical lymphadenopathy. He also had a five-year

    history of dizziness. Computed tomography, magnetic resonance imaging

    and positron emission tomography showed cervical, mediastinal and

    inguinal lymphadenopathy. Intracranial tumors and pelvic bone lesions were

    also detected. The cervical lymph node biopsy confirmed the diagnosis of

    Rosai-Dorfman disease. The patient received oral prednisolone, and his

    neck pain was improved. The massive cervical lymph nodes and bone

    lesions didn’t progress.

    Conclusion: Rosai-Dorfman disease should be considered in the differential

    diagnosis of lymphadenopathy, even though the disease is rare. The

    predominant clinical manifestation of the disease is painless cervical

    lymphadenopathy. Rosai-Dorfman disease is considered a benign disease,

    however the disease can be fatal because of cellular infiltration and mass

    forming. The treatment for Rosai-Dorfman disease has not been established.

    Figure 1: Axial CT and positron emission tomography show multiple bilateral cervical lymphadenopathy (SUV MAX: 14.25).

    Rosai-Dorfman disease is a rare, benign, idiopatic, and non-neoplastic

    histiocytic disorder. It’s characterized by massive but painless cervical

    lymphadenopathy, fever, leukocytosis, increased erythrocyte sedimentation

    rate, and polyclonal hypergammaglobulinemia [1]. Most patients present

    with lympthatic involvement, whereas 43% of cases are extranodal

    presentations: eyelids, orbit, respiratory tract, salivary glands, skin, bone,

    testis, lung, kidney, central nervous system, thyroid and gastrointestinal tract

    [2]. Figure 3: Axial MR image shows multiple bone lesions of the skull.

    Figure 4: (A) Photomicrograph shows the foamy histiocytes, which contain intact lymphocytes and/or plasma cells within their cytoplasm, termed emperipolesis. (hematoxylin and eosin staining); (B) The histiocytes show positive reactions for S-100 protein in immunohistochemical staining.

    lymph node and intracranial tumor identified histiocytes that engulfed

    lymphocytes and plasma cells in their cytoplasm (emperipolesis) (Figure 4A).

    The immunohistochemical staining revealed positive S-100 staining of

    histiocytes (Figure 4B). Histopathological and immunohistochemical studies

    established the diagnosis of Rosai-Dorfman disease. The neck pain

    appeared, and the oral administration of prednisolone improved his

    symptoms. No evidence of residual or recurrent tumor in the intracranial

    lesion was identified. The size of bone lesions and lymph nodes were stable.

    Sinus histocytosis with massive lymphadenopathy, also known as

    Rosai-Dorfman disease, is an idiopathic histiocytic proliferation affecting

    lymph nodes. Histologically, the lesions consisted of variable numbers of

    pale-staining histiocytes with emperipolesis. In this case, the patient had

    multiple lymphadenopathy, central nervous system involvements and bone

    lesions. The differential diagnosis of Rosai-Dorfman disease is broad and

    includes malignant glioma, malignant lymphoma, histiocytosis X

    (Langerhans cell histiocytosis), sarcoidosis, metastatic tumors,

    granulomatous disease and meningioma [3][4]. Rosai-Dorfman disease has

    a long natural history with mostly benign course, and special treatment is not

    required. However, massive lymphadenopathy, extranodal involvement of

    multiple organs (kidney, lungs and liver), immunologic abnormalities and

    anemia can lead to a poor prognosis. The treatment modalities for Rosai-

    Dorfman disease include corticosteroids, chemotherapy with a combination

    of vinca alkaloids and alkylating agents, low-dose interferon, antibiotic

    therapy, radiation therapy and surgical treatment [5]. However, there is no

    established treatment for Rosai-Dorfman disease.

    A 53 year- old man was admitted to our hospital because of three-

    month history of bilateral massive painless cervical lymphadenopathy and

    five-year history of dizziness. On physical examination, he had enlarged

    bilateral cervical lymph nodes. He had normal vital signs and no

    neurological abnormality. Hematological and biochemical examinations were

    normal without leukocytosis and hypergammaglobulinemia. Computed

    tomography, magnetic resonance imaging and positron emission

    tomography showed cervical, mediastinal and inguinal lymphadenopathy.

    Intracranial tumors and multiple lytic bone lesions of the skull and pelvic

    bone were also detected (Figure 1-3). The patient underwent cervical lymph

    node biopsy and intracranial tumor resection. The histological examinations

    of the cervical

    1) Rosai J, Dorfman RF. Arch Pathol. 1969 Jan;87(1):63-70.

    2) Foucar E, Rosai J, Dorfman R. Semin Diagn Pathol. 1990 Feb;7(1):19-73.

    3) Loh SY, Tan KB, Wong YS, et al. J Bone Joint Surg Am. 2004 Mar;86-A(3):595-8.

    4) Fukushima T, Yachi K, Ogino A, et al. Neurol Med Chir (Tokyo). 2011;51(2):136-40.

    5) Komp DM. Semin Diagn Pathol. 1990 Feb;7(1):83-6.

    A B

    Figure 5: Frontal (left) and lateral (right) view of CT-angiography show intracranial tumor with hypervascularity.